-
公开(公告)号：US20080176878A1
公开(公告)日：2008-07-24
申请号：US11901813
申请日：2007-09-18
IPC分类号： A61K31/505 , C07D239/24 , A61P9/00
CPC分类号： C07D239/42
摘要： Provided is a crystalline form of rosuvastatin calcium characterized by X-ray powder diffraction peaks at about 4.7, 19.4 and 22.3° 2 theta±0.2° 2 theta and processes for the preparation thereof.
摘要翻译： 提供的是瑞舒伐他汀钙的结晶形式，其特征在于在约4.7,19.4和22.3°2θ±0.2°2θ的X射线粉末衍射峰，其制备方法。
-
公开(公告)号：US20060252770A1
公开(公告)日：2006-11-09
申请号：US11488810
申请日：2006-07-17
IPC分类号： A61K31/496 , C07D403/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
-
公开(公告)号：US07868169B2
公开(公告)日：2011-01-11
申请号：US11506030
申请日：2006-08-16
IPC分类号： C07D239/42 , C07D403/12
CPC分类号： C07D239/42
摘要： Provided is a crystalline rosuvastatin intermediate and processes for preparation thereof.
摘要翻译： 提供了结晶瑞舒伐他汀中间体及其制备方法。
-
公开(公告)号：US20050288302A1
公开(公告)日：2005-12-29
申请号：US11208299
申请日：2005-08-19
IPC分类号： C07D215/56 , A61K31/496 , C07D43/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin denominated forms A, B, C, D, E1, F, G, H, I, and J, and methods for their preparation. Also provided are methods for making known crystalline forms of gatifloxacin, in particular forms omega and T2RP.
-
公开(公告)号：US20060258674A1
公开(公告)日：2006-11-16
申请号：US11488367
申请日：2006-07-17
IPC分类号： A61K31/496 , C07D403/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
-
公开(公告)号：US20060252772A1
公开(公告)日：2006-11-09
申请号：US11488812
申请日：2006-07-17
IPC分类号： A61K31/496 , C07D403/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
-
公开(公告)号：US20060252771A1
公开(公告)日：2006-11-09
申请号：US11488811
申请日：2006-07-17
IPC分类号： A61K31/496 , C07D403/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.
-
公开(公告)号：US20050288301A1
公开(公告)日：2005-12-29
申请号：US11208248
申请日：2005-08-19
IPC分类号： C07D215/56 , A61K31/496 , C07D43/02
CPC分类号： C07D215/56
摘要： Provided are novel crystalline forms of gatifloxacin denominated forms A, B, C, D, E1, F, G, H, I, and J, and methods for their preparation. Also provided are methods for making known crystalline forms of gatifloxacin, in particular forms omega and T2RP.
摘要翻译： 提供加替沙星命名形式为A，B，C，D，E1，F，G，H，I和J的新型结晶形式及其制备方法。 还提供了制备加替沙星的已知结晶形式的方法，特别是形成ω和T2RP。
-
公开(公告)号：US20080269488A1
公开(公告)日：2008-10-30
申请号：US12217251
申请日：2008-07-01
IPC分类号： C07D401/10
CPC分类号： C07D215/56 , C07D401/04
摘要： Provided are two novel crystalline forms of gatifloxacin, denominated form O and form V, and methods for their preparation.
摘要翻译： 提供加替沙星的两种新型结晶形式，称为O型和V型，其制备方法。
-
公开(公告)号：US07396839B2
公开(公告)日：2008-07-08
申请号：US10635337
申请日：2003-08-06
IPC分类号： C07D401/04
CPC分类号： C07D215/56 , C07D401/04
摘要： Provided are novel crystalline forms of gatifloxacin, denominated forms L, M, P, Q, S, and T1, and methods for making them. Also provided are methods of transforming the novel crystalline forms of gatifloxacin of the present invention to other crystalline forms of gatifloxacin.
摘要翻译： 提供加替沙星的新型结晶形式，称为L，M，P，Q，S和T1，以及制备它们的方法。 还提供了将本发明的加替沙星的新结晶形式转化为加替沙星的其它结晶形式的方法。
-
-
-
-
-
-
-
-
-
搜索结果
91 条记录 (耗时 0.028 秒)
